3.56

0.57% 0.01

Rocket Pharmaceuticals Inc (RCKT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Rocket Pharmaceuticals Inc stock is traded at $3.56, with a volume of 1.57M. It is up +0.57% in the last 24 hours and up +7.53% over the past month. Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

Previous Close:

$3.55

Open:

$3.57

24h Volume:

1.57M

Relative Volume:

0.68

Market Cap:

$385.81M

Revenue:

Net Income/Loss:

$-258.08M

P/E Ratio:

-1.2945

EPS:

-2.75

Net Cash Flow:

$-202.32M

1W Performance:

+4.39%

1M Performance:

+7.53%

6M Performance:

+23.11%

1Y Performance:

-71.09%

1-Day Range:

$3.505

$3.67

1-Week Range:

$3.38

$3.67

52-Week Range:

$2.19

$13.30

Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile

Name

Rocket Pharmaceuticals Inc

Sector

Healthcare (1126)

Industry

Biotechnology (624)

Phone

646-440-9100

Address

350 FIFTH AVENUE, NEW YORK, NY

Employee

299

Twitter

@rocketpharma

Next Earnings Date

2024-11-04

Latest SEC Filings

RCKT's Discussions on Twitter

Compare RCKT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RCKT Rocket Pharmaceuticals Inc	3.565	384.19M	0	-258.08M	-202.32M	-2.75
VRTX Vertex Pharmaceuticals Inc	467.92	113.87B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	773.55	80.22B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	405.75	52.56B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	801.69	49.31B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	174.75	37.37B	447.02M	-1.18B	-906.14M	-6.1812

Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-18-25	Downgrade	JP Morgan	Neutral → Underweight
Aug-20-25	Upgrade	BofA Securities	Neutral → Buy
Jul-25-25	Downgrade	BofA Securities	Buy → Neutral
May-30-25	Downgrade	Evercore ISI	Outperform → In-line
May-28-25	Downgrade	Goldman	Neutral → Sell
May-28-25	Downgrade	JP Morgan	Overweight → Neutral
May-28-25	Downgrade	Jefferies	Buy → Hold
May-28-25	Downgrade	Leerink Partners	Outperform → Market Perform
May-28-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight
May-27-25	Downgrade	Needham	Buy → Hold
May-27-25	Downgrade	TD Cowen	Buy → Hold
Mar-12-25	Initiated	BMO Capital Markets	Outperform
Dec-30-24	Initiated	Wedbush	Outperform
Dec-18-24	Initiated	Jefferies	Buy
Oct-16-24	Initiated	Scotiabank	Sector Outperform
Apr-02-24	Initiated	Goldman	Neutral
Oct-24-23	Initiated	Cantor Fitzgerald	Overweight
Feb-01-23	Initiated	Morgan Stanley	Overweight
Nov-08-22	Initiated	Canaccord Genuity	Buy
Nov-01-22	Initiated	BTIG Research	Buy
Jul-08-22	Initiated	Raymond James	Outperform
Oct-20-21	Resumed	Cowen	Outperform
Mar-02-21	Initiated	Stifel	Buy
Feb-18-21	Initiated	Needham	Buy
Dec-16-20	Initiated	UBS	Buy
Dec-08-20	Downgrade	Oppenheimer	Outperform → Perform
Jul-02-20	Initiated	JP Morgan	Overweight
Jun-25-20	Resumed	BofA/Merrill	Buy
Jun-01-20	Resumed	Oppenheimer	Outperform
Nov-06-19	Initiated	Chardan Capital Markets	Buy
Sep-26-19	Initiated	Piper Jaffray	Overweight
Apr-23-19	Initiated	Robert W. Baird	Outperform
Mar-15-19	Initiated	BofA/Merrill	Buy
Feb-05-19	Initiated	Oppenheimer	Outperform
Sep-13-18	Initiated	Ladenburg Thalmann	Buy
Jul-10-18	Initiated	William Blair	Outperform

View All

Rocket Pharmaceuticals Inc Stock (RCKT) Latest News

08:02 AM

Will Rocket Pharmaceuticals Inc. Equity Warrant stock continue upward momentum2026 world cup usa national team round of 16 goalkeepers low block defense knockout prediction analysis - Улправда

08:02 AM

Jan 05, 2026

Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference - BioSpace

Jan 05, 2026

Jan 02, 2026

What analysts say about Rocket Pharmaceuticals Inc stockPortfolio Risk Assessment & Double Or Triple Capital - earlytimes.in

Jan 02, 2026

Jan 01, 2026

How Rocket Pharmaceuticals Inc. Equity Warrant stock performs in weak economyStochastic Oscillator Alerts & Rapid Capital Trading - bollywoodhelpline.com

Jan 01, 2026

Dec 31, 2025

The Truth About Rocket Pharmaceuticals: Is RCKT About To Explode Or Crash? - AD HOC NEWS

Dec 31, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Cross Below 50 Day Moving AverageShould You Sell? - MarketBeat

Dec 31, 2025

Dec 27, 2025

Can Rocket Pharmaceuticals Inc. Equity Warrant stock maintain growth trajectoryHigh Yield Income Stocks & Connect With Bulls, Avoid the Bears - bollywoodhelpline.com

Dec 27, 2025

Dec 26, 2025

Rocket Pharmaceuticals: Upside On LAD-I Approval And Amended Danon Program - Seeking Alpha

Dec 26, 2025

Is Rocket Pharmaceuticals (RCKT) One of the Best NASDAQ Stocks Under $5 to Buy Now? - MSN

Dec 26, 2025

Dec 23, 2025

Published on: 2025-12-24 06:58:20 - earlytimes.in

Dec 23, 2025

Dec 20, 2025

Will Rocket Pharmaceuticals Inc. Equity Warrant stock remain a Wall Street favoriteWeekly Profit Analysis & Long Hold Capital Preservation Plans - Улправда

Dec 20, 2025

How buybacks impact Rocket Pharmaceuticals Inc. stock valueMarket Rally & Expert Approved Momentum Trade Ideas - Улправда

Dec 20, 2025

Will Rocket Pharmaceuticals Inc. Equity Warrant stock outperform Nasdaq indexJuly 2025 Weekly Recap & Daily Entry Point Alerts - Bölüm Sonu Canavarı

Dec 20, 2025

Is Rocket Pharmaceuticals Inc. Equity Warrant stock dividend yield sustainableJuly 2025 Snapshot & Real-Time Chart Breakout Alerts - Улправда

Dec 20, 2025

Dec 19, 2025

Can Rocket Pharmaceuticals Inc. Equity Warrant stock sustain institutional interest2025 Breakouts & Breakdowns & Weekly Top Performers Watchlists - Улправда

Dec 19, 2025

Can Rocket Pharmaceuticals Inc. stock hit analyst price targetsMarket Risk Report & Daily Entry Point Alerts - Улправда

Dec 19, 2025

What margin trends mean for Rocket Pharmaceuticals Inc. Equity Warrant stockJuly 2025 Pullbacks & Real-Time Volume Spike Alerts - Улправда

Dec 19, 2025

Published on: 2025-12-19 17:54:30 - DonanımHaber

Dec 19, 2025

Will Rocket Pharmaceuticals Inc. stock rally after Fed decisions2025 Retail Activity & Long-Term Growth Portfolio Plans - DonanımHaber

Dec 19, 2025

Will Rocket Pharmaceuticals Inc. Equity Warrant stock maintain dividend yieldJuly 2025 Levels & Safe Swing Trade Setups - DonanımHaber

Dec 19, 2025

Stop Loss: Will Rocket Pharmaceuticals Inc. Equity Warrant stock rally after Fed decisionsWeekly Risk Report & Verified Short-Term Trading Plans - DonanımHaber

Dec 19, 2025

Rally Mode: What is the fair value of Rocket Pharmaceuticals Inc. stock nowJuly 2025 WrapUp & Low Drawdown Trading Techniques - ulpravda.ru

Dec 19, 2025

Dec 18, 2025

Why analysts remain bullish on Rocket Pharmaceuticals Inc. stockWeekly Trade Report & High Accuracy Trade Alerts - Улправда

Dec 18, 2025

Published on: 2025-12-18 21:01:52 - Улправда

Dec 18, 2025

Published on: 2025-12-18 16:59:15 - Улправда

Dec 18, 2025

Market Fear: Will Rocket Pharmaceuticals Inc. Equity Warrant stock continue upward momentum2025 Market Overview & Intraday High Probability Alerts - Улправда

Dec 18, 2025

Published on: 2025-12-18 16:13:14 - Улправда

Dec 18, 2025

Dec 17, 2025

Rocket Pharmaceuticals Leads Our Trio Of Penny Stock Contenders - Yahoo Finance

Dec 17, 2025

Dec 16, 2025

Analysts Are Bullish on Top Healthcare Stocks: Novan (NOVN), Palvella Therapeutics (PVLA) - The Globe and Mail

Dec 16, 2025

Rocket Pharmaceuticals (RCKT) Stock Target Reduced Following Q3 2025 Update on Cash Position - Finviz

Dec 16, 2025

Dec 14, 2025